| Dr Peter Langenstroer, MD | |
|
9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226-3522 | |
| (414) 805-0805 | |
| (414) 805-0771 |
| Full Name | Dr Peter Langenstroer |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 33 Years |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780635532 | NPI | - | NPPES |
| 1780635532 | Medicaid | WI | |
| 002000225F | Other | HUMANA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 34766 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
| St Josephs Community Hospital West Bend | West bend, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
| Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
News Archive
Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus' spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein cholesterol levels is often inaccurate.
For years, the majority of research on reactive oxygen species (ROS) - ions or very small molecules that include free radicals - has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses.
› Verified 2 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus' spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein cholesterol levels is often inaccurate.
For years, the majority of research on reactive oxygen species (ROS) - ions or very small molecules that include free radicals - has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses.
› Verified 2 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus' spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein cholesterol levels is often inaccurate.
For years, the majority of research on reactive oxygen species (ROS) - ions or very small molecules that include free radicals - has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Langenstroer, MD 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226-3522 Ph: (414) 805-0805 | Dr Peter Langenstroer, MD 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226-3522 Ph: (414) 805-0805 |
News Archive
Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus' spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein cholesterol levels is often inaccurate.
For years, the majority of research on reactive oxygen species (ROS) - ions or very small molecules that include free radicals - has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses.
› Verified 2 days ago
Mark Ehlers, Urology Medicare: Medicare Enrolled Practice Location: 2801 W Kinnickinnic River Pkwy Ste 330, Milwaukee, WI 53215 Phone: 414-649-1280 Fax: 414-649-1288 | |
Dr. Michael L Guralnick, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Dr. Arman Cicic, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd Ste 580, Milwaukee, WI 53226 Phone: 414-476-0430 | |
Dr. Pedro M. Banda, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2311 N Prospect Ave, Milwaukee, WI 53211 Phone: 414-319-3000 Fax: 414-319-3087 | |
Dr. Jay I Sandlow, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Dept Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Joshua Alan Bodie, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Department Of Urology, Milwaukee, WI 53226 Phone: 414-805-0805 Fax: 414-805-0771 | |
Mr. Michael Ernst Mitchell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-3666 |